Cranbrook Wealth Management’s Avanos Medical AVNS Stock Holding History

Cranbrook Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13	Closed	–	–	307
2022 Q1	$0	Buy	+13	New	+$419	﹤0.01%	347

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Cranbrook Wealth Management's AVNS Position: Q2 2022 in Review

Cranbrook Wealth Management sold out of Avanos Medical (AVNS) in Q2 2022, closing a stake of 13 shares.

Cranbrook Wealth Management first reported a position in AVNS in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

Cranbrook Wealth Management reported no remaining Avanos Medical position as of Q2 2022 after selling out during the quarter.
Cranbrook Wealth Management sold 13 Avanos Medical shares in Q2 2022.
Cranbrook Wealth Management first reported a position in Avanos Medical in Q1 2022 and held it in 1 quarter.
Cranbrook Wealth Management's Avanos Medical position peaked at $0 in Q1 2022.
287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on Cranbrook Wealth Management's 13F filing for Q2 2022, filed 28 Jul 2022.